quinolinic acid has been researched along with edaravone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Purushothaman, B; Ramachandran, S; Sumathi, T; Vedagiri, A | 1 |
| Altomare, A; Mercolini, L; Mondanelli, G; Protti, M; Regazzoni, L; Sanz, I; Valsecchi, V; Volpi, C | 1 |
2 other study(ies) available for quinolinic acid and edaravone
| Article | Year |
|---|---|
Quinolinic Acid-Induced Huntington Disease-Like Symptoms Mitigated by Potent Free Radical Scavenger Edaravone-a Pilot Study on Neurobehavioral, Biochemical, and Histological Approach in Male Wistar Rats.
Topics: Animals; Brain; Edaravone; Free Radical Scavengers; Huntington Disease; Lipid Peroxidation; Male; Neuroprotective Agents; Quinolinic Acid; Rats; Rats, Wistar | 2018 |
Chromatographic measurement of 3-hydroxyanthranilate 3,4-dioxygenase activity reveals that edaravone can mitigate the formation of quinolinic acid through a direct enzyme inhibition.
Topics: 3-Hydroxyanthranilate 3,4-Dioxygenase; 3-Hydroxyanthranilic Acid; Amyotrophic Lateral Sclerosis; Edaravone; Humans; Neurodegenerative Diseases; Quinolinic Acid | 2022 |